Solésence Tops $62.1M Revenue in 2025 with 27% Q4 Gross Margin
Solésence delivered record 2025 revenue of $62.1 million, up 19%, with fourth-quarter gross profit climbing to $3.4 million on a 27% margin, versus 22% a year earlier. The company introduced its Transform & Transcend initiative to drive operational excellence, market expansion, service innovation and global partnerships.
1. Record Full-Year 2025 Revenue and Profit
Solésence generated $62.1 million in revenue for the twelve months ended December 31, 2025, a 19% increase from $52.3 million in 2024. Full-year gross profit totaled $16.1 million, delivering a 26% margin, and net income reached $1.8 million.
2. Fourth-Quarter Margin and Profit Improvement
In Q4 2025, revenue was $12.5 million, flat year-over-year, while gross profit rose 21% to $3.4 million, expanding margin to 27% from 22%, and net income turned positive at $0.2 million versus a $0.6 million loss.
3. Transform & Transcend Strategic Initiative
The company launched Transform & Transcend, centered on operational excellence, technology-driven market expansion, service model innovation and global partnerships, aiming to leverage recent growth and intellectual property to drive sustainable, profitable expansion.
4. Leadership, Partnerships and Patent Expansion
Solésence appointed Yoolie Park as Vice President of Brand Partnerships, added 20 new facial skincare and color cosmetics partners, and secured 16 U.S. and international patents across its Kleair skin health technology and plant-based pipeline.